Search Results - therapeutics+%3e+oncology

UCLA researchers from the Department of Integrative Biology and Physiology have developed a novel method to identify rare 3’ UTR variants that regulate mRNA abundance, with potential applications in predicting cancer patient survival. BACKGROUND: Non-coding genetic variants play a significant role in diseases such as cancer yet identifying those...

Published: 9/17/2025 | Inventor(s): Xinshu Xiao

Keywords(s):

Category(s): Life Science Research Tools > Screening Libraries, Therapeutics > Oncology

Double-Stranded RNA Expression Signatures to Predict Response to Cancer Therapy (UCLA Case No. 2022-218)

UCLA researchers from the Department of Integrative Biology and Physiology have developed a novel method to profile RNA editing in single cells from lung cancer biopsies as a method to predict patient survival. BACKGROUND: RNA editing occurs naturally in the human transcriptome and has been shown to influence cancer cell behavior and the anti-tumor...

Published: 9/17/2025 | Inventor(s): Xinshu Xiao, Ting Fu

Keywords(s):

Category(s): Diagnostic Markers > Cancer, Therapeutics > Oncology, Therapeutics > Immunology And Immunotherapy

POLQ as a Mediator of Radioresistance in Prostate Cancer (UCLA Case No. 2024-068)

Please contact UCLA Technology Development Group for more information. KEYWORDS: cancer biology, cancer therapy resistance, molecular oncology, drug discovery, radiosensitization, radioresistance mechanisms, predictive biomarkers, prostate cancer

Published: 9/13/2025 | Inventor(s): Paul Boutros

Keywords(s):

Category(s): Therapeutics > Oncology, Diagnostic Markers

TRP: Sequence of Anti-EMP2 Monoclonal Antibody (UCLA Case No. 2021-369)

Tangible Research Property: Sequence of Anti-EMP2 Monoclonal Antibody. Dr. Madhuri Wadehra's research and discovery efforts are focused on two related themes in tumor biology: understanding the function of a tetraspan protein epithelial membrane protein-2 (EMP2) in tumor progression, and developing therapeutic and diagnostic agents that target...

Published: 9/10/2025 | Inventor(s): Madhuri Wadehra

Keywords(s):

Category(s): Life Science Research Tools, Therapeutics > Oncology

Bioelectric Neuromodulation Methods for Hematopoiesis Regulation During Chemotherapy (Case No. 2020-382)

Summary: UCLA researchers in the Department of Bioengineering have developed an electrical neuromodulation method to accelerate recovery from deleterious chemotherapy side effects to improve patient outcome. Background: Chemotherapy works by targeting and killing fast-growing cancer cells using anti-cancer drugs. However, because these drugs lack...

Published: 8/21/2025 | Inventor(s): Wentai Liu

Keywords(s): algorithmic cancer detection, Bladder Cancer, blood cancers, Brain cancer, Breast Cancer, Cancer, cancer antigen, cancer detection, Cancer Immunotherapy, cancer inhibition, cancer metabolism, Cancer stem cells, cancer target, castration resistant prostate cancer, Chemotherapy, head and neck cancer, lympathic cancers, lymphatic cancer, Mesenchymal Stem Cell Derived Cancer Cells, Neuromodulation, non-small cell lung cancer, Orthotopic cancer models, Pancreatic cancer, prostate cancer, small cell cancer, small cell lung cancer, small cell prostate cancer

Category(s): Medical Devices, Medical Devices > Neural Stimulation, Chemical, Electrical, Therapeutics, Therapeutics > Oncology

1 2 3 4 5 6 7 8 9 10 ...